Hepion Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2024.
  • Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $28.6K, a 81% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $792K, a 67.2% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $792K, a 67.2% decline from 2023.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.42M, a 5.32% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.55M, a 45.3% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $792K -$1.63M -67.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-08
2023 $2.42M -$136K -5.32% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-08
2022 $2.55M -$2.12M -45.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $4.67M +$2.29M +96.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-10
2020 $2.38M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2015 $2.12M +$1.92M +985% Jul 1, 2014 Jun 30, 2015 10-K 2015-09-25
2014 $195K Jul 1, 2013 Jun 30, 2014 10-K 2015-09-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.